Document Detail


Hyaluronidase reversal of increased coronary vascular resistance in ischemic rat hearts.
MedLine Citation:
PMID:  6881354     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Testicular hyaluronidase prevents increased coronary vascular resistance (CVR) during prolonged myocardial ischemia. The mechanism is unknown, but edema and contracture both have been suggested to increase CVR. Additionally, the extent of contracture has been inversely related to ATP levels. Therefore, isolated perfused ischemic rat hearts were treated with hyaluronidase, following a 25% increase in CVR, to determine whether 1) increased CVR was reversed, 2) edema or contracture was reduced, and 3) tissue ATP levels were increased. Three hours of low-flow ischemia decreased coronary flow (CF) from 17.4 +/- 0.13 to 12.6 +/- 0.2 ml X min-1 X g dry tissue-1. During the subsequent 2 h of ischemia, CF of vehicle-treated hearts continued to decline to 8.0 +/- 0.76 ml X min-1 X g dry tissue-1, whereas CF of hyaluronidase-treated hearts increased to 15.6 +/- 1.17 ml X min-1 X g dry tissue-1. These changes in CF persisted during postischemic perfusion. Furthermore, restoration of coronary vascular resistance by hyaluronidase was associated with a 19% reduction in tissue water compared with control ischemic hearts but not with a reduction in cardiac contracture or an increase in tissue ATP. These results suggest that treatment of ischemic hearts with hyaluronidase reverses increased CVR through a reduction in tissue edema.
Authors:
K P Sunnergren; M J Rovetto
Related Documents :
21894544 - Myocardial perfusion scintigraphy in europe 2007: a survey of the european council of n...
10567324 - Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: ...
7634444 - Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
9800814 - High-flow gas insufflation to facilitate midcabg: effects on coronary endothelium.
8865984 - Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin t...
618594 - Hemodynamic components of a cardiogenic hypertensive chemoreflex in dogs.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of physiology     Volume:  245     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1983 Aug 
Date Detail:
Created Date:  1983-09-20     Completed Date:  1983-09-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H183-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Aerobiosis
Animals
Blood Pressure
Coronary Disease / physiopathology*
Coronary Vessels / drug effects,  physiopathology*
Disease Models, Animal
Hyaluronoglucosaminidase / pharmacology*
Kinetics
Male
Myocardium / metabolism
Rats
Rats, Inbred Strains
Vascular Resistance / drug effects*
Grant Support
ID/Acronym/Agency:
HL-00922/HL/NHLBI NIH HHS; HL-27336/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
56-65-5/Adenosine Triphosphate; EC 3.2.1.35/Hyaluronoglucosaminidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vasopressin modulates liver regeneration in the Brattleboro rat.
Next Document:  Impaired baroreflex control of vascular resistance in prehypertensive Dahl S rats.